{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:34:12Z","timestamp":1786998852124,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>\n                      Safety and immunological activity of donor blood monocyte\u2013derived regulatory dendritic cells (DCreg) generated ex vivo have been demonstrated recently in living donor liver transplantation. A potential alternative\/additional source of DCreg precursors is the allograft perfusion fluid. Our goal was to establish the extent to which DCreg could be generated from CD14\n                      <jats:sup>+<\/jats:sup>\n                      myeloid precursors in living donor liver perfusate (LD-LP) and to assess the phenotype and immunoregulatory properties of the perfusate-derived DCreg (LP-DCreg).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      Presumptive DCreg were generated from CD14\n                      <jats:sup>+<\/jats:sup>\n                      precursors recovered from n = 14 right lobe liver grafts using GM-CSF + Interleukin (IL)-4, with the addition of vitamin D3 and IL-10. Control immature DC and corresponding Toll-like receptor 4 agonist monophosphoryl lipid A (MPLA)\u2013stimulated DC populations were also generated. Cell phenotype and function, DCreg maturation resistance, T-cell allostimulatory activity, and the roles of immunoregulatory molecules in llograft perfusate (LP)-DCreg function were analyzed by flow cytometry, RT-PCR analysis, cytokine assays, and MLR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Presumptive DCreg generated from live donor-LP comprised relatively high proportions of CD141\n                      <jats:sup>hi<\/jats:sup>\n                      CD163\n                      <jats:sup>+<\/jats:sup>\n                      cells. They expressed comparatively high coinhibitory programmed death ligand-1 (PD-L1):costimulatory molecule (CD86) ratios, even after MPLA stimulation. Moreover, unlike immature DC, they produced high levels of IL-10 but minimal\/low proinflammatory IL-12 and tumor necrosis factor alpha following MPLA stimulation. These LP-DCreg were poor stimulators of na\u00efve allogeneic T cells and suppressed alloreactive CD4 and CD8 T-cell proliferation. Blocking of the PD-L1-PD-1 signaling pathway reversed their regulatory function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Liver graft perfusate constitutes a novel source of myeloid precursors for DCreg generation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005787","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:00:23Z","timestamp":1781118023000},"page":"e1657-e1668","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Generation of Regulatory Dendritic Cells From Living Donor Liver Transplant Perfusates"],"prefix":"10.1097","volume":"110","author":[{"given":"Rosalia","family":"Bus\u00e0","sequence":"first","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."},{"name":"Research Department, IRCCS-ISMETT, Palermo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Zahorchak","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Macedo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Mitsufuji","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Metes","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."},{"name":"Department of Immunology, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Badami","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Fondazione RIMED, Palermo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth D.","family":"Elinoff","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi G.","family":"Lakkis","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."},{"name":"Department of Immunology, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Humar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giulio","family":"Conaldi","sequence":"additional","affiliation":[{"name":"Research Department, IRCCS-ISMETT, Palermo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."},{"name":"Department of Immunology, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.21821","article-title":"Renal outcomes after liver transplantation in the model for end-stage liver disease era.","volume":"15","author":"Sharma","year":"2009","journal-title":"Liver Transpl"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/lt.21803","article-title":"Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.","volume":"15","author":"Karie-Guigues","year":"2009","journal-title":"Liver Transpl"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance.","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3227","article-title":"Regulatory immune cells in transplantation.","volume":"12","author":"Wood","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.trre.2019.05.001","article-title":"Regulatory dendritic cells for human organ transplantation.","volume":"33","author":"Thomson","year":"2019","journal-title":"Transplant Rev (Orlando, Fla.)"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","article-title":"Dendritic cells as inducers of peripheral tolerance.","volume":"38","author":"Iberg","year":"2017","journal-title":"Trends Immunol"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"633436","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease.","volume":"12","author":"Ness","year":"2021","journal-title":"Front Immunol"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/tri.12889","article-title":"Tolerogenic dendritic cell therapy in organ transplantation.","volume":"30","author":"Moreau","year":"2017","journal-title":"Transpl Int"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MOT.0000000000001127","article-title":"Regulatory dendritic cell therapy in organ transplantation.","volume":"29","author":"Hadjiyannis","year":"2024","journal-title":"Curr Opin Organ Transplant"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/tri.13504","article-title":"Tolerogenic dendritic cells in organ transplantation.","volume":"33","author":"Ochando","year":"2020","journal-title":"Transpl Int"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/ajt.12310","article-title":"Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.","volume":"13","author":"Ezzelarab","year":"2013","journal-title":"Am J Transplant"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.humimm.2017.10.017","article-title":"Regulatory dendritic cells for promotion of liver transplant operational tolerance: rationale for a clinical trial and accompanying mechanistic studies.","volume":"79","author":"Thomson","year":"2018","journal-title":"Hum Immunol"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/ajt.16393","article-title":"Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients.","volume":"21","author":"Macedo","year":"2021","journal-title":"Am J Transplant"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"eadf4287","DOI":"10.1126\/scitranslmed.adf4287","article-title":"Donor-derived regulatory dendritic cell infusion modulates effector CD8(+) T cell and NK cell responses after liver transplantation.","volume":"15","author":"Tran","year":"2023","journal-title":"Sci Transl Med"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/s41467-026-71280-8","article-title":"Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I\/IIa trial.","volume":"17","author":"Humar","year":"2026","journal-title":"Nat Commun"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment.","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/lt.20659","article-title":"Characterization of human liver dendritic cells in liver grafts and perfusates.","volume":"12","author":"Bosma","year":"2006","journal-title":"Liver Transpl"},{"key":"R18-20260817","first-page":"1111","article-title":"Human liver transplant perfusate: an abundant source of donor liver-associated leukocytes.","volume":"26","author":"Jonsson","year":"1997","journal-title":"Hepatology"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellimm.2017.08.008","article-title":"High PD-L1\/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation.","volume":"323","author":"Zahorchak","year":"2018","journal-title":"Cell Immunol"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jcyt.2022.11.005","article-title":"Manufacturing and validation of good manufacturing practice-compliant regulatory dendritic cells for infusion into organ transplant recipients.","volume":"25","author":"Zahorchak","year":"2023","journal-title":"Cytotherapy"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/hep.30334","article-title":"DNAX activating protein of 12\u2009kDa\/triggering receptor expressed on myeloid cells 2 expression by mouse and human liver dendritic cells: functional implications and regulation of liver ischemia-reperfusion injury.","volume":"70","author":"Nakao","year":"2019","journal-title":"Hepatology"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41423-019-0218-0","article-title":"Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10).","volume":"17","author":"Comi","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S2213-8587(20)30104-2","article-title":"Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes.","volume":"8","author":"Nikolic","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"1054968","DOI":"10.3389\/fimmu.2022.1054968","article-title":"Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients.","volume":"13","author":"Nikolic","year":"2022","journal-title":"Front Immunol"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"EVIDoa2300238","DOI":"10.1056\/EVIDoa2300238","article-title":"Novel autologous dendritic cell therapy AVT001 for type 1 diabetes.","volume":"3","author":"Gaglia","year":"2024","journal-title":"NEJM Evid"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"290ra87","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients.","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.1820039116","article-title":"Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"e030309","DOI":"10.1136\/bmjopen-2019-030309","article-title":"Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.","volume":"9","author":"Willekens","year":"2019","journal-title":"BMJ Open"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ecco-jcc\/jjv144","article-title":"Intraperitoneal administration of autologous tolerogenic dendritic cells for refractory Crohn\u2019s disease: a phase I study.","volume":"9","author":"Jauregui-Amezaga","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.kint.2022.08.037","article-title":"A phase I\/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.","volume":"103","author":"Moreau","year":"2023","journal-title":"Kidney Int"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri1256","article-title":"Dendritic cells: emerging pharmacological targets of immunosuppressive drugs.","volume":"4","author":"Hackstein","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R33-20260817","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1873-3468.15017","article-title":"Leveraging current insights on IL-10-producing dendritic cells for developing effective immunotherapeutic approaches.","volume":"599","author":"Morali","year":"2025","journal-title":"FEBS Lett"},{"key":"R34-20260817","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.3390\/ijms22147363","article-title":"Transfection of vitamin D3-induced tolerogenic dendritic cells for the silencing of potential tolerogenic genes. identification of CSF1R-CSF1 signaling as a glycolytic regulator.","volume":"22","author":"Mansilla","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R35-20260817","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases.","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"key":"R36-20260817","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2013.08.007","article-title":"CD141\u207a myeloid dendritic cells are enriched in healthy human liver.","volume":"60","author":"Kelly","year":"2014","journal-title":"J Hepatol"},{"key":"R37-20260817","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J Exp Med"},{"key":"R38-20260817","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway.","volume":"116","author":"Gregori","year":"2010","journal-title":"Blood"},{"key":"R39-20260817","doi-asserted-by":"crossref","first-page":"103051","DOI":"10.1016\/j.jaut.2023.103051","article-title":"Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.","volume":"138","author":"Passeri","year":"2023","journal-title":"J Autoimmun"},{"key":"R40-20260817","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/hep.29529","article-title":"Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance.","volume":"67","author":"Ono","year":"2018","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"R41-20260817","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1038\/s41598-023-36629-9","article-title":"Immunomodulatory response in an experimental model of brain death.","volume":"13","author":"Santana","year":"2023","journal-title":"Sci Rep"},{"key":"R42-20260817","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.trim.2007.10.007","article-title":"Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.","volume":"18","author":"Horibe","year":"2008","journal-title":"Transpl Immunol"},{"key":"R43-20260817","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/micr.30128","article-title":"Recipient bone marrow-derived stromal cells prolong graft survival in a rat hind limb allotransplantation model.","volume":"37","author":"Ikeguchi","year":"2017","journal-title":"Microsurgery"},{"key":"R44-20260817","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/TP.0000000000004288","article-title":"Apheresis of deceased donors as a new source of mobilized peripheral blood hematopoietic stem cells for transplant tolerance.","volume":"107","author":"Sosa","year":"2023","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:00:29Z","timestamp":1786996829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005787","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}